Kuguaglycoside C, a constituent of Momordica charantia, induces caspase-independent cell death of neuroblastoma cells

Cancer Science

Volumn 103, Issue 12, 2012, Pages 2153-2158

  Tabata, Keiichi ^a   Hamano, Aoi ^a   Akihisa, Toshihiro ^a   Suzuki, Takashi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CASPASE; HOE 33342; KUGUAGLYCOSIDE C; MOMORDICA CHARANTIA EXTRACT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CYTOTOXICITY; DNA CLEAVAGE; FLOW CYTOMETRY; FLUORESCENCE HISTOCHEMISTRY; HUMAN; HUMAN CELL; IC 50; MOMORDICA CHARANTIA; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REACTION TIME; STAINING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL DEATH; DNA CLEAVAGE; FLOW CYTOMETRY; GLYCOSIDES; HUMANS; MOMORDICA CHARANTIA; NEUROBLASTOMA; POLY(ADP-RIBOSE) POLYMERASES; SAPONINS; TUMOR CELLS, CULTURED;

EID: 84870696123     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12021     Document Type: Article

References (31)

1. Cohn SL, Pearson AD, London WB et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009; 27: 289-97.
2. Perwein T, Lackner H, Sovinz P et al. Survival and late effects in children with stage 4 neuroblastoma. Pediatr Blood Cancer 2011; 57: 629-35.
3. Vasudevan SA, Nuchtern JG, Shohet JM. Gene profiling of high risk neuroblastoma. World J Surg 2005; 29: 317-24.
4. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 1993; 85: 377-84.
5. Vogan K, Bernstein M, Leclerc JM et al. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 1993; 53: 5269-73.
6. Teitz T, Lahti JM, Kidd VJ. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J Mol Med 2001; 79: 428-36.
7. McComb S, Cheung HH, Korneluk RG, Wang S, Krishnan L, Sad S. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ 2012; 19 (11): 1791-801.
8. Delavallée L, Cabon L, Galán-Malo P, Lorenzo HK, Susin SA. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life 2011; 63: 221-32.
9. Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. Br J Nutr 2009; 102: 1703-8.
10. Nerurkar P, Ray RB. Bitter melon: antagonist to cancer. Pharm Res 2010; 27: 1049-53.
11. Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 2004; 93: 123-32.
12. Brennan VC, Wang CM, Yang WH. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling. J Med Food 2012; 15: 325-34.
13. Ray RB, Raychoudhuri A, Steele R, Nerurkar P. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res 2010; 70: 1925-31.
14. Pitchakarn P, Ogawa K, Suzuki S et al. Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Sci 2010; 101: 2234-40.
15. Pitchakarn P, Suzuki S, Ogawa K et al. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf. Cancer Lett 2011; 306: 142-50.
16. Chen JC, Lu L, Zhang XM, Zhou L, Li ZR, Qiu MH. Eight new cucurbitane glycosides, kuguaglycosides A-H, from the root of Momordica charantia L. Helv Chim Acta 2008; 91: 920-9.
17. Russell J, Wheldon TE, Stanton P. A radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. Cancer Res 1995; 55: 4915-21.
18. Burkhart CA, Cheng AJ, Madafiglio J et al. Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma. J Natl Cancer Inst 2003; 95: 1394-403.
19. Hopkins-Donaldson S, Yan P, Bourloud KB, Muhlethaler A, Bodmer JL, Gross N. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells. Oncogene 2002; 21: 6132-7.
20. Pitchakarn P, Suzuki S, Ogawa K et al. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3. Food Chem Toxicol 2012; 50: 840-7.
21. Li F. Survivin study: what is the next wave? J Cell Physiol 2003; 197: 8-29.
22. Pavlyukov MS, Antipova NV, Balashova MV, Vinogradova TV, Kopantzev EP, Shakhparonov MI. Survivin monomer plays an essential role in apoptosis regulation. J Biol Chem 2011; 286: 23296-307.
23. Croci DO, Cogno IS, Vittar NB et al. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway. J Cell Biochem 2008; 105: 381-90.
24. Long JS, Ryan KM. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene 2012; doi: 10.1038/onc.2012.7.
25. Vanlangenakker N, Bertrand MJ, Bogaert P, Vandenabeele P, Berghe TV. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis 2011; 2: e230.
26. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res 2000; 256: 12-18.
27. Counis MF, Torriglia A. Acid DNases and their interest among apoptotic endonucleases. Biochimie 2006; 88: 1851-8.
28. Soldani C, Scovassi AI. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 2002; 7: 321-8.
29. Zhang Y, Zhang G, Hendrix LR, Tesh VL, Samuel JE. Coxiella burnetii induces apoptosis during early stage infection via a caspase-independent pathway in human monocytic THP-1 cells. PLoS ONE 2012; 7: e30841.
30. Kaiser WJ, Upton JW, Long AB et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011; 471: 368-72.
31. L complex inhibits RIPK3-dependent necrosis. Nature 2011; 471: 363-7.